These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 33065776)
1. Autologous stem cell transplant in first remission for transformed indolent non-Hodgkin lymphoma: additional data to guide practice. Reneau JC; William BM Br J Haematol; 2020 Dec; 191(5):663-665. PubMed ID: 33065776 [No Abstract] [Full Text] [Related]
2. Autologous hematopoietic stem cell transplant in first remission in non-Hodgkin's lymphoma. Tomblyn M; Winter JN Expert Rev Anticancer Ther; 2003 Jun; 3(3):281-94. PubMed ID: 12820773 [TBL] [Abstract][Full Text] [Related]
3. Phase I/II study of bortezomib-BEAM and autologous hematopoietic stem cell transplantation for relapsed indolent non-Hodgkin lymphoma, transformed, or mantle cell lymphoma. William BM; Allen MS; Loberiza FR; Bociek RG; Bierman PJ; Armitage JO; Vose JM Biol Blood Marrow Transplant; 2014 Apr; 20(4):536-42. PubMed ID: 24434781 [TBL] [Abstract][Full Text] [Related]
4. High dose chemotherapy with autologous stem cell transplant for patients with transformed B-cell non-Hodgkin lymphoma in the rituximab era. Blaker YN; Eide MB; Liestøl K; Lauritzsen GF; Kolstad A; Fosså A; Smeland EB; Holte H Leuk Lymphoma; 2014 Oct; 55(10):2319-27. PubMed ID: 24432894 [TBL] [Abstract][Full Text] [Related]
5. Hematopoietic stem cell transplantation for non-Hodgkin lymphoma. Bhatt VR; Vose JM Hematol Oncol Clin North Am; 2014 Dec; 28(6):1073-95. PubMed ID: 25459180 [TBL] [Abstract][Full Text] [Related]
6. Autologous stem cell transplantation and stem cell mobilization kinetics in elderly patients with B cell non-Hodgkin lymphoma. Dogu MH; Çagirgan S; Ocakci S; Kaya AH; Ilkkilic K; Sanli NM; Kahraman S; Eren R; Tekgunduz E; Hacioglu S; Kaynar L; Erkurt MA; Altuntas F Transfus Apher Sci; 2017 Dec; 56(6):814-818. PubMed ID: 29153347 [TBL] [Abstract][Full Text] [Related]
7. Favorable outcomes from allogeneic and autologous stem cell transplantation for patients with transformed nonfollicular indolent lymphoma. Villa D; George A; Seymour JF; Toze CL; Crump M; Lee C; Buckstein R; Stewart DA; MacDonald D; Foley R; Xenocostas A; Sabloff M; Chua N; Couture F; Larouche JF; Cohen S; Savage KJ; Connors JM; Panzarella T; Carney DA; Dickinson M; Kuruvilla J Biol Blood Marrow Transplant; 2014 Nov; 20(11):1813-8. PubMed ID: 25042735 [TBL] [Abstract][Full Text] [Related]
8. Stem cell transplantation for non-Hodgkin's lymphoma. Wrench D; Gribben JG Hematol Oncol Clin North Am; 2008 Oct; 22(5):1051-79, xi. PubMed ID: 18954751 [TBL] [Abstract][Full Text] [Related]
9. Activity of single-agent melphalan 220-300 mg/m2 with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphoma. Phillips GL; Meisenberg BR; Reece DE; Adams VR; Badros AZ; Brunner JL; Fenton RG; Filicko J; Grosso DL; Hale GA; Howard DS; Johnson VP; Kniska A; Marshall KW; Mookerjee B; Nath R; Rapoport AP; Sarkodee-Adoo C; Takebe N; Vesole DH; Wagner JL; Flomenberg N Bone Marrow Transplant; 2004 Apr; 33(8):781-7. PubMed ID: 14767498 [TBL] [Abstract][Full Text] [Related]
10. Reappraising the role of autologous transplantation for indolent B-cell lymphomas in the chemoimmunotherapy era: is it still relevant? Hamadani M Bone Marrow Transplant; 2013 Aug; 48(8):1013-21. PubMed ID: 23000653 [TBL] [Abstract][Full Text] [Related]
11. The role of hematopoietic stem cell transplantation in non-Hodgkin lymphoma. Villanueva ML; Vose JM Clin Adv Hematol Oncol; 2006 Jul; 4(7):521-30. PubMed ID: 17147239 [TBL] [Abstract][Full Text] [Related]
12. [Autologous stem-cell transplantations in children with non-Hodgkin lymphomas]. Wójcik B; Kowalczyk JR; Chybicka A; Wachowiak J; Drabko K; Zaucha-Prazmo A; Choma M; Gorczyńska E; Toporski J; Turkiewicz D; Kałwak K; Pieczonka A; Boruczkowski D Przegl Lek; 2004; 61 Suppl 2():53-6. PubMed ID: 15686047 [TBL] [Abstract][Full Text] [Related]
13. Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission. Vose JM; Rizzo DJ; Tao-Wu J; Armitage JO; Bashey A; Burns LJ; Christiansen NP; Freytes CO; Gale RP; Gibson J; Giralt SA; Herzig RH; Lemaistre CF; McCarthy PL; Nimer SD; Petersen FB; Schenkein DP; Wiernik PH; Wiley JM; Loberiza FR; Lazarus HM; van Biesen K; Horowitz MM Biol Blood Marrow Transplant; 2004 Feb; 10(2):116-27. PubMed ID: 14750077 [TBL] [Abstract][Full Text] [Related]